INTRODUCTION AND OBJECTIVES: Ghrelin, a 28 amino acid growth hormone, is widely distributed throughout the peripheral and central nervous systems. Ghrelin 0 s many physiological functions include growth promotion, suppression of inflammation, and enhancement of food intake. Increasingly, evidence suggests an antinociceptive role of ghrelin in murine pain models. However, whether ghrelin also plays a role in controlling the micturition reflex is unclear. Therefore, we investigated the effects of intravenous administration of ghrelin on the micturition reflex in rats.
INTRODUCTION AND OBJECTIVES: Ghrelin, a 28 amino acid growth hormone, is widely distributed throughout the peripheral and central nervous systems. Ghrelin 0 s many physiological functions include growth promotion, suppression of inflammation, and enhancement of food intake. Increasingly, evidence suggests an antinociceptive role of ghrelin in murine pain models. However, whether ghrelin also plays a role in controlling the micturition reflex is unclear. Therefore, we investigated the effects of intravenous administration of ghrelin on the micturition reflex in rats.
METHODS: Continuous cystometrograms (CMG, 0.04 ml/min) were performed in female Sprague-Dawley rats (228-252 g) under urethane anesthesia. Stable micturition cycles were established, and ghrelin was then administered intravenously to evaluate changes in bladder activity. In experiments examining the role of opioid systems, ghrelin was administered intravenously when the first bladder contraction was observed after intravenous administration of naloxone methiodide, an opioid receptor antagonist. Cystometric parameters were recorded and compared before and after drug administration.
RESULTS: Intravenous administration of ghrelin at 300, 600, and 900 μg/kg (n[6 per dose) increased intercontraction intervals in a dose-dependent fashion to 119.1 AE 3.8%, 147.5 AE 8.3%, and 154.4 AE 11.5% of the control value, respectively (p <0.01). These inhibitory effects were seen immediately after administration and returned to the pre-control level within 80 minutes. Intravenous administration of ghrelin at 300, 600, and 900 μg/kg (n[6 per dose) also increased threshold pressure in a dose-dependent fashion to 9.58 AE 1.03 cmH 2 O, 12.7 AE 1.51 cmH 2 O, and 15.6 AE 3.11 cmH 2 O, respectively (p <0.01). There were no significant changes in baseline pressure or residual urine at any doses tested. These inhibitory effects of ghrelin (900 μg/kg, n[6) were antagonized by intravenous administration of naloxone methiodide (3 mg/kg, n[6).
CONCLUSIONS: These results indicate that in urethaneanesthetized rats, ghrelin inhibits the micturition reflex through the opioid mechanism. Thus, ghrelin could be effective for the treatment of bladder dysfunction, such as overactive bladder.
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MP11-13 CENTRALLY ADMINISTERED BOMBESIN INDUCES FREQUENT URINATION VIA BRAIN CORTICOTROPIN-RELEASING FACTOR RECEPTOR TYPE 1 IN RATS
Takahiro Shimizu*, Suo Zou, Shogo Shimizu, Nankoku, Japan; Naoki Wada, Shun Takai, Nobutaka Shimizu, Pittsburgh, PA; Masaki Yamamoto, Youichirou Higashi, Nankoku, Japan; Naoki Yoshimura, Pittsburgh, PA; Motoaki Saito, Nankoku, Japan INTRODUCTION AND OBJECTIVES: Psychological stress exacerbates bladder dysfunction such as overactive bladder (OAB) and bladder pain syndrome/interstitial cystitis (BPS/IC). We previously reported that bombesin (BB), a stress-related neuropeptide, centrally induces facilitation of the rat micturition reflex. Brain BB is reported to activate hypothalamo-pituitary-adrenal axis and sympathetic nerves, as representative responses to stressful conditions, via brain corticotropinreleasing factor (CRF), another stress-related neuropeptide. Therefore, we examined whether brain CRF is involved in the BB-induced frequent urination in rats.
METHODS: (1) In urethane anesthetized (0.8 g/kg, ip) male Sprague-Dawley (SD) rats (300-400 g), a catheter was inserted into the bladder to perform cystometry (CMG, 12 ml/h saline infusion). Astressin (a non-selective CRF receptor antagonist, 1 or 3 nmol/rat) was intracerebroventricularly (icv) pretreated 60 min before BB administration (0.03 nmol/rat, icv). CMG was started 60 min before the first icv administration.
(2) By using urethane anesthetized (0.8 g/kg, ip) male Wistar rats (300-400 g), similar surgery and CMG experiments described above were performed. Three hours after the surgery, CP154526 (CP, a selective antagonist of CRF receptor type 1 (CRF1 receptor), 3 or 10 nmol/rat) or K41498 (a selective antagonist of CRF receptor type 2, 10 nmol/rat) was icv pretreated 30 min before BB administration (0.03 nmol/rat, icv).
RESULTS: Icv administered BB significantly reduced intercontraction interval (ICI) compared to the pre-treatment values before BB (-10w0 min) (Figs. A-C) without affecting maximal voiding pressure (data not shown) in both SD and Wistar rats. Icv pretreated astressin or CP dose-dependently suppressed the BB-induced ICI reduction (Figs. A-B) , but K41498 showed no significant effect on the BBinduced ICI reduction (Fig. C) .
CONCLUSIONS: Brain BB system is involved in facilitation of the rat micturition reflex via brain CRF1 receptors. These findings would be useful for understanding the underlying brain mechanisms of psychological stress-related exacerbation of lower urinary tract symptoms in OAB and BPS/IC, for which brain CRF1 receptors could be a new therapeutic target.
